✦ LIBER ✦

Natalizumab treatment reduces endothelial activity in MS patients

✍ Scribed by Alban Millonig; Harald Hegen; Franziska Di Pauli; Rainer Ehling; Claudia Gneiss; Martina Hoelzl; Bettina Künz; Andreas Lutterotti; Dagmar Rudzki; Thomas Berger; Markus Reindl; Florian Deisenhammer

Book ID: 113730720
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 261 KB
Volume: 227
Category: Article
ISSN: 0165-5728
DOI: 10.1016/j.jneuroim.2010.07.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natalizumab reduces loss of visual funct

Natalizumab reduces loss of visual function in MS

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Minimal supportive treatment in natalizu

Minimal supportive treatment in natalizumab-related PML in a MS patient

✍ Lalive, P. H.; Bridel, C.; Ferfoglia, R. I.; Kaiser, L.; Du Pasquier, R.; Barkho 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 336 KB

PML: underdiagnosed in MS patients on na

PML: underdiagnosed in MS patients on natalizumab

✍ Israel Steiner 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 43 KB

Natalizumab reduces hospitalisations in

Natalizumab reduces hospitalisations in patients with CD

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Natalizumab shows promise in the treatme

Natalizumab shows promise in the treatment of MS

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

PML: underdiagnosed in MS patients on na

PML: underdiagnosed in MS patients on natalizumab – Authors' reply

✍ David B Clifford; Avindra Nath 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 54 KB